Braveheart Investment Group Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Braveheart Investment Group hat ein Gesamteigenkapital von £3.5M und eine Gesamtverschuldung von £0.0, was einen Verschuldungsgrad von 0% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen £3.5M bzw. £43.6K.

Wichtige Informationen

Verhältnis von Schulden zu Eigenkapital

UK£0

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	UK£1.09m
Eigenkapital	UK£3.46m
Gesamtverbindlichkeiten	UK£43.60k
Gesamtvermögen	UK£3.50m

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: BRHDie kurzfristigen Aktiva des Unternehmens (£1.2M) übersteigen seine kurzfristigen Passiva (£43.6K).

Langfristige Verbindlichkeiten: BRH hat keine langfristigen Verbindlichkeiten.

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: BRH ist schuldenfrei.

Schulden abbauen: BRH hatte vor 5 Jahren keine Schulden.

Schuldendeckung: BRH hat keine Schulden und muss daher nicht durch den operativer Cashflow gedeckt werden.

Zinsdeckung: BRH hat keine Schulden, daher ist die Deckung der Zinszahlungen kein Problem.

Braveheart Investment Group Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

CEO & Non-Executive Director recently bought UK£91k worth of stock

First half 2025 earnings released: EPS: UK£0.001 (vs UK£0.011 loss in 1H 2024)

Braveheart Investment Group plc (AIM:BRH) acquired 29.51% stake in IQ-AI Limited (LSE:IQAI) from Trevor Brown and Free Association Books Limited for £0.719 million.

Braveheart Investment Group plc (AIM:BRH) acquired an additional 15% stake in Gyrometric Systems Limited for £0.0225 million.

Insufficient new directors

Full year 2024 earnings released: UK£0.11 loss per share (vs UK£0.027 profit in FY 2023)

Braveheart Investment Group plc, Annual General Meeting, Jul 18, 2024

Bruker Uk Limited completed the acquisition of Phasefocus Holdings Limited from Braveheart Investment Group plc (AIM:BRH) and other shareholders.

Bruker Uk Limited entered into a conditional sale and purchase agreement to acquire Phasefocus Holdings Limited from Braveheart Investment Group plc (AIM:BRH) and other shareholders for £5 million.

First half 2024 earnings released: UK£0.011 loss per share (vs UK£0.01 loss in 1H 2023)

New minor risk - Share price stability

New major risk - Market cap size

Braveheart Investment Group plc, Annual General Meeting, Jul 28, 2023

Full year 2023 earnings released: EPS: UK£0.027 (vs UK£0.031 in FY 2022)

Less than half of directors are independent

First half 2023 earnings released: UK£0.012 loss per share (vs UK£0.049 profit in 1H 2022)

Braveheart Investment Group plc (AIM:BRH) acquired additional 4.7% stake in Autins Group plc (AIM:AUTG) for £0.16 million.

Braveheart Investment Group plc (AIM:BRH) acquired additional 8.31% minority stake in Aukett Swanke Group Plc (AIM:AUK) from Andrew Murdoch for £0.33 million.

Braveheart Investment Group plc (AIM:BRH) agreed to acquire a 7.89% stake in Aukett Swanke Group Plc (AIM : AUK) from Trevor Brown for £0.22 million.

Braveheart Investment Group plc Provides the Update on Paraytec

Full year 2022 earnings released: EPS: UK£0.031 (vs UK£0.37 in FY 2021)

Less than half of directors are independent

Less than half of directors are independent

First half 2022 earnings released: EPS UK£0.049 (vs UK£0.013 in 1H 2021)

Braveheart Investment Group plc Announces Further Update re Paraytec AD Scanner Project

CEO & Director recently sold UK£556k worth of stock

Full year 2021 earnings released

Braveheart Investment Group plc Updates on the Paraytec AD Scanner Project

David Orton, Paul Orton and Janet Poliakoff agreed to acquire a 56.07% stake in Gyrometric Systems Limited from Braveheart Investment Group plc (AIM:BRH) and Remote Monitored Systems plc (AIM:RMS).

CEO & Director recently sold UK£827k worth of stock

Independent Non-Executive Director has left the company

CEO & Director recently sold UK£1.7m worth of stock

CEO & Director recently sold UK£689k worth of stock

New 90-day high: UK£0.80

Braveheart Investment Group plc Provides Update Concerning Progress to Develop Covid-19 Test That Paraytec Limited Is Working on in Conjunction with the University of Sheffield

CEO & Director recently sold UK£214k worth of stock

First half 2021 earnings released: EPS UK£0.013

New 90-day high: UK£0.47

New 90-day high: UK£0.37

Remote Monitored Systems plc (AIM:RMS) agree to acquire 51.72% stake in Pharm 2 Farm Limited from Braveheart Investment Group plc (AIM:BRH) for £1.2 million.

Braveheart Investment Group plc Update on the Pharm2farm Anti-Viral Mask Project

New 90-day high - UK£0.21

New 90-day high - UK£0.21

New 90-day high - UK£0.20

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Entdecken Sie finanziell stabile Unternehmen